HilleVax, Inc.(HLVX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HLVX HilleVax, Inc.

盘后交易 09-16 19:18:38 EDT

1.79

-0.04

-2.19%

盘后1.79

+0.00-0.09%

17:00 EDT

最高1.85	最低1.78	成交量12.61万
今开1.83	昨收1.83	日振幅3.83%
总市值8,542万	流通市值3,423万	总股本4,772万
成交额22.72万	换手率0.66%	流通股本1,912万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"HLVX","market":"US","secType":"STK","nameCN":"HilleVax, Inc.","latestPrice":1.79,"timestamp":1726516800000,"preClose":1.83,"halted":0,"volume":126088,"hourTrading":{"tag":"盘后","latestPrice":1.7884,"preClose":1.79,"latestTime":"17:00 EDT","volume":2615,"amount":4680.686301,"timestamp":1726520453538},"delay":0,"floatShares":19121373,"shares":47723188,"eps":-3.391189,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.04,"latestTime":"09-16 19:18:38 EDT","open":1.83,"high":1.85,"low":1.78,"amount":227209.5925136,"amplitude":0.038251,"askPrice":1.94,"askSize":100,"bidPrice":1.71,"bidSize":11,"shortable":3,"etf":0,"ttmEps":-3.391189,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1726531200000},"adr":0,"listingDate":1651204800000,"adjPreClose":1.83,"preHourTrading":{"tag":"盘前","latestPrice":1.83,"preClose":1.83,"latestTime":"09:04 EDT","volume":13,"amount":23.3699999,"timestamp":1726491877776},"postHourTrading":{"tag":"盘后","latestPrice":1.7884,"preClose":1.79,"latestTime":"17:00 EDT","volume":2615,"amount":4680.686301,"timestamp":1726520453538},"volumeRatio":0.710375},"requestUrl":"/m/hq/s/HLVX","defaultTab":"news","newsList":[{"id":"2459515477","title":"Hillevax, Inc.2024财年第二财季实现净利润-40.67百万美元，同比减少45.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459515477","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459515477?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:03","pubTimestamp":1723737815,"startTime":"0","endTime":"0","summary":"8月16日，Hillevax, Inc.公布财报，公告显示公司2024财年第二财季净利润为-40.67百万美元，同比减少45.77%；其中营业收入为0.00美元，每股基本收益为-0.83美元。从资产负债表来看，Hillevax, Inc.总负债72.00百万美元，其中短期债务29.18百万美元，资产负债比为0.04，流动比率为0.06。机构评级：截至2024年8月16日，当前有3家机构对Hillevax, Inc.目标价做出预测，其中目标均价为3.33美元，其中最低目标价为2.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000349959be73c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000349959be73c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HLVX"],"gpt_icon":0},{"id":"2459839186","title":"Hillevax, Inc.盘中异动 大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459839186","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459839186?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:31","pubTimestamp":1723563093,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时31分，Hillevax, Inc.股票出现异动，股价快速拉升5.03%。Hillevax, Inc.股票所在的生物技术行业中，整体涨幅为1.86%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为133.27%、125.78%、31.29%，振幅较大的相关个股有冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029、Tempest Therapeutics, Inc.，振幅分别为68.79%、40.95%、39.71%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132331339682609c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132331339682609c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HLVX","BK4139","VLP"],"gpt_icon":0},{"id":"2458411323","title":"Hillevax, Inc.盘中异动 下午盘股价大涨5.28%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458411323","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458411323?lang=zh_cn&edition=full","pubTime":"2024-08-09 02:38","pubTimestamp":1723142334,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日02时38分，Hillevax, Inc.股票出现波动，股价快速拉升5.28%。截至发稿，该股报1.70美元/股，成交量21.2417万股，换手率0.43%，振幅4.35%。Hillevax, Inc.股票所在的生物技术行业中，整体涨幅为3.76%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Aldeyra Therapeutics, Inc.、Biovie Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为435.90%、299.70%、204.26%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为139.88%、54.41%、45.58%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809023854af96a3b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809023854af96a3b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VLP","HLVX","BK4139"],"gpt_icon":0},{"id":"2457418978","title":"Hillevax, Inc.盘中异动 早盘急速拉升5.06%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457418978","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457418978?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:31","pubTimestamp":1723037504,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时31分，Hillevax, Inc.股票出现异动，股价急速上涨5.06%。截至发稿，该股报1.66美元/股，成交量2.1676万股，换手率0.04%，振幅2.53%。Hillevax, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Scorpius Holdings, Inc.、Aditxt, Inc.、Silo Pharma, Inc.较为活跃，换手率分别为263.61%、143.38%、42.21%，振幅较大的相关个股有Aditxt, Inc.、Neurosense Therapeutics Ltd.、天境生物，振幅分别为16.93%、13.79%、12.26%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721314496824c7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721314496824c7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HLVX","VLP"],"gpt_icon":0},{"id":"2457211040","title":"Hillevax, Inc.盘中异动 急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457211040","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457211040?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:40","pubTimestamp":1722955225,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日22时40分，Hillevax, Inc.股票出现异动，股价大幅拉升5.04%。Hillevax, Inc.股票所在的生物技术行业中，整体涨幅为2.10%。其相关个股中，Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Scorpius Holdings, Inc.涨幅较大，Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1144.45%、1027.46%、340.58%，振幅较大的相关个股有Vbi Vaccines, Inc.、Anew Medical Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为168.52%、70.73%、52.93%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062240259682462b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062240259682462b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VLP","HLVX","BK4139"],"gpt_icon":0},{"id":"2457778884","title":"Hillevax, Inc.盘中异动 大幅跳水6.76%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457778884","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457778884?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:33","pubTimestamp":1722864812,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时33分，Hillevax, Inc.股票出现异动，股价急速下挫6.76%。截至发稿，该股报1.59美元/股，成交量7.2504万股，换手率0.15%，振幅1.18%。Hillevax, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Zevra Therapeutics, Inc.、Okyo Pharma Ltd Com Npv 、Pasithea Therapeutics Corp.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为995.74%、37.04%、13.57%，振幅较大的相关个股有Vor Biopharma Inc.、Compass Therapeutics, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为13.04%、12.65%、12.03%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213332957f2eeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213332957f2eeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VLP","HLVX","BK4139"],"gpt_icon":0},{"id":"2456195049","title":"BUZZ-HilleVax 宣布裁员，股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2456195049","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456195049?lang=zh_cn&edition=full","pubTime":"2024-08-01 05:14","pubTimestamp":1722460446,"startTime":"0","endTime":"0","summary":"    7月31日 - ** 疫苗开发商 HilleVax    盘后股价下跌 6% 至 1.72 美元 ** 公司宣布裁员约41人，约占员工总数的40%，以减少运营开支 ** 裁员是为了保留现金，因为公司 \"正在探索继续开发 HIL-214 和 HIL-216 诺如病毒候选疫苗的潜力\"。** 公司预计裁员将产生约 340 万美元的相关费用** 预计裁员将基本完成，大部分相关费用将在 2024 年第三季度确认- HLVX ** HLVX 表示将停止  婴儿 HIL-214 的开发，股价在本月早些时候创下历史新低。** 截至上次收盘，股价累计下跌 88.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLVX","BK4139","BUZZ"],"gpt_icon":0},{"id":"2453979516","title":"Hillevax, Inc.盘中异动 急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453979516","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453979516?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:52","pubTimestamp":1721656359,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时52分，Hillevax, Inc.股票出现异动，股价快速拉升5.08%。截至发稿，该股报1.86美元/股，成交量16.3165万股，换手率0.33%，振幅4.52%。Hillevax, Inc.股票所在的生物技术行业中，整体涨幅为1.25%。其相关个股中，木薯科学、Mei Pharma, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为105.39%、84.54%、24.18%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、木薯科学、Hepion Pharmaceuticals, Inc.，振幅分别为31.84%、27.08%、24.75%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222152409681ee6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222152409681ee6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HLVX","VLP"],"gpt_icon":0},{"id":"2451919261","title":"Hillevax, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451919261","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451919261?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:11","pubTimestamp":1721142696,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时11分，Hillevax, Inc.股票出现异动，股价急速拉升5.14%。截至发稿，该股报1.84美元/股，成交量31.9452万股，换手率0.64%，振幅3.43%。Hillevax, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Silo Pharma, Inc.、Virpax Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2612.75%、1223.45%、355.63%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.，振幅分别为79.41%、61.68%、57.94%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231136af929bad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231136af929bad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","HLVX","VLP","VRPX"],"gpt_icon":1},{"id":"2450396153","title":"Hillevax, Inc.盘中异动 大幅拉升5.52%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450396153","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450396153?lang=zh_cn&edition=full","pubTime":"2024-07-12 01:25","pubTimestamp":1720718710,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日01时25分，Hillevax, Inc.股票出现异动，股价急速上涨5.52%。Hillevax, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Neximmune, Inc.、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc涨幅较大，Neximmune, Inc.、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited较为活跃，换手率分别为1514.42%、654.88%、644.90%，振幅较大的相关个股有Neximmune, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为205.40%、149.14%、97.11%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。消息层面，截至01时25分，《Guggenheim：下调HilleVax评级》资讯为影响Hillevax, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712012510941f6567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712012510941f6567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HLVX","VLP"],"gpt_icon":0},{"id":"2450816206","title":"Hillevax, Inc.盘中异动 股价大跌5.30%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450816206","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450816206?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:56","pubTimestamp":1720619782,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时56分，Hillevax, Inc.股票出现波动，股价大幅下跌5.30%。Hillevax, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为2027.78%、946.57%、585.84%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Longeveron Inc.，振幅分别为119.83%、62.50%、59.23%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。消息层面，截至21时56分，《Guggenheim：下调HilleVax评级》资讯为影响Hillevax, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710215623af919d5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710215623af919d5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VLP","BK4139","HLVX","LGVN","BK4007","VRPX"],"gpt_icon":0},{"id":"2450028160","title":"Hillevax, Inc.盘中异动 早盘股价大涨5.79%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450028160","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450028160?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:33","pubTimestamp":1720531982,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时33分，Hillevax, Inc.股票出现波动，股价快速拉升5.79%。截至发稿，该股报1.74美元/股，成交量202.429万股，换手率4.07%，振幅5.45%。Hillevax, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。消息层面，截至21时33分，《Guggenheim：下调HilleVax评级》资讯为影响Hillevax, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092133029f25b706&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092133029f25b706&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HLVX","VLP"],"gpt_icon":0},{"id":"2450017623","title":"HC Wainwright &amp; Co.：下调HilleVax(HLVX.US)评级，由买入调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450017623","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450017623?lang=zh_cn&edition=full","pubTime":"2024-07-09 18:47","pubTimestamp":1720522034,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HLVX","BK4139"],"gpt_icon":0},{"id":"2450085161","title":"Guggenheim：下调HilleVax(HLVX.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2450085161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450085161?lang=zh_cn&edition=full","pubTime":"2024-07-09 01:32","pubTimestamp":1720459955,"startTime":"0","endTime":"0","summary":"Guggenheim：下调HilleVax(HLVX.US)评级，由买入调整至中性评级。HilleVax(HLVX.US)公司简介：HilleVax Inc是一家临床阶段的生物制药公司。它专注于新型疫苗的开发和商业化。该公司的初始项目HIL-214是一种基于病毒样颗粒(VLP)的候选疫苗，用于预防由诺如病毒感染引起的中重度急性肠胃炎(AGE)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090135509591d076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090135509591d076&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HLVX"],"gpt_icon":0},{"id":"2450088163","title":"Guggenheim：下调HilleVax(HLVX.US)评级，由买入调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450088163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450088163?lang=zh_cn&edition=full","pubTime":"2024-07-09 00:46","pubTimestamp":1720457160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","HLVX"],"gpt_icon":0},{"id":"2449048597","title":"更新版 1-HilleVax 将停止开发婴儿诺如病毒疫苗；股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2449048597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449048597?lang=zh_cn&edition=full","pubTime":"2024-07-08 23:02","pubTimestamp":1720450974,"startTime":"0","endTime":"0","summary":"     路透7月8日 - 周一，HilleVax   股价暴跌87.6%，创下1.75美元的历史新低，因为这家生物技术公司表示将停止开发用于婴儿的诺如病毒候选疫苗。HilleVax 公司表示，它将停止 HIL-214 在婴儿中的进一步开发，并将探索是否能在成人中继续进行同样的开发。HilleVax于今年1月从成都康华生物制品  获得了HIL-216在大中华区以外的开发和商业化 。诺如病毒是导致呕吐、腹泻和其他食源性疾病的主要原因之一。目前，莫德纳    和 Vaxart    也在开发诺如病毒疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4501","BK4585","BK4568","BK4532","BK4588","HLVX","MRNA","BK4534","300841","BK4548","BK4533","VXRT","BK4551","BK0239"],"gpt_icon":0},{"id":"2449096709","title":"HilleVax Inc.（HLVX）股价下跌88%，这家临床阶段生物医药公司宣布，其面向婴儿的诺如病毒疫苗候选药HIL-214在2b阶段研究失败——没能实现主要终点或次要有效终点，将不再开发。","url":"https://stock-news.laohu8.com/highlight/detail?id=2449096709","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449096709?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:38","pubTimestamp":1720449498,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4139","HIL","399441","161726","159646","HLVX","BK4123"],"gpt_icon":0},{"id":"2449570397","title":"Hillevax, Inc.股价重挫85.99% 市值跌8422.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449570397","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449570397?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:31","pubTimestamp":1720445467,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时31分，Hillevax, Inc.股票出现波动，股价快速下跌85.99%。截至发稿，该股报1.97美元/股，成交量643.029万股，换手率12.93%，振幅0.06%。Hillevax, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Morphic Holding, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Cero Therapeutics Holdings, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为153.45%、126.07%、104.31%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Dyadic International, Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为8.66%、7.64%、6.94%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131079590a74f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131079590a74f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRPX","BK4007","HLVX","VLP"],"gpt_icon":0},{"id":"2449772442","title":"BUZZ-诺如病毒疫苗中期研究失败，HilleVax 公司股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2449772442","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449772442?lang=zh_cn&edition=full","pubTime":"2024-07-08 20:31","pubTimestamp":1720441865,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    7月8日 - ** 疫苗开发商 HilleVax    的股价盘前下跌 ~90.1% 至 1.40 美元** 该公司称其诺如病毒疫苗 HIL-214 在约 5 个月大的婴儿中的测试未达到 (link) 目标** 表示将停止在婴儿中进一步开发该疫苗** 在中期研究中，疫苗没有显示出对肠胃炎（胃黏膜炎症）的疗效** 诺如病毒会引起呕吐、腹泻和其他食源性疾病** 截至上次收盘，股价累计下跌 12.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","HLVX","BK4139"],"gpt_icon":0},{"id":"2448660041","title":"Hillevax, Inc.盘中异动 临近午盘大幅拉升5.13%报15.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448660041","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448660041?lang=zh_cn&edition=full","pubTime":"2024-07-02 23:30","pubTimestamp":1719934202,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日23时30分，Hillevax, Inc.股票出现波动，股价快速上涨5.13%。截至发稿，该股报15.16美元/股，成交量2.6617万股，换手率0.05%，振幅6.38%。Hillevax, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。Hillevax, Inc.公司简介：HilleVax Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702233003941f3293&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702233003941f3293&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VLP","HLVX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hillevax.com","stockEarnings":[{"period":"1week","weight":0.0517},{"period":"1month","weight":0.0893},{"period":"3month","weight":-0.8787},{"period":"6month","weight":-0.8983},{"period":"1year","weight":-0.8652},{"period":"ytd","weight":-0.886}],"compareEarnings":[{"period":"1week","weight":0.0401},{"period":"1month","weight":0.0336},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.1023},{"period":"1year","weight":0.2479},{"period":"ytd","weight":0.1824}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"HilleVax, Inc.于2020年3月25日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化新型疫苗。该公司的初始项目HIL-214是一种基于病毒样颗粒(VLP)的候选疫苗，用于预防由诺如病毒感染引起的中度至重度急性胃肠炎(AGE)。公司计划在2022年第二季度启动2b期临床试验，以评估HIL-214在婴儿中的安全性、免疫原性和有效性。","exchange":"NASDAQ","name":"HilleVax, Inc.","nameEN":"HilleVax, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HilleVax, Inc.(HLVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供HilleVax, Inc.(HLVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"HilleVax, Inc.,HLVX,HilleVax, Inc.股票,HilleVax, Inc.股票老虎,HilleVax, Inc.股票老虎国际,HilleVax, Inc.行情,HilleVax, Inc.股票行情,HilleVax, Inc.股价,HilleVax, Inc.股市,HilleVax, Inc.股票价格,HilleVax, Inc.股票交易,HilleVax, Inc.股票购买,HilleVax, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HilleVax, Inc.(HLVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供HilleVax, Inc.(HLVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}